Chemotherapy sensitivity and resistance testing: to be “standard” or to be individualized, that is the question

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gastric Cancer

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10120-006-0366-7PMID 16767362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

  2006cited by this paper
• Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

  2005cited by this paper
• Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)

  2005cited by this paper
• Current Status of Cell Culture Drug Resistance Testing ( CCDRT ) May , 2002

  2005cited by this paper
• Adjuvant chemotherapy with uracil-tegafur (UFT) for serosa negative advanced gastric cancer : results of a randomized trial by the National Surgical Adjuvant Study of Gastric Cancer

  2005cited by this paper
• American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.

  2004cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Chemotherapy sensitivity and resistance assays: a systematic review.

  2004cited by this paper
• Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur

  2004cited by this paper
• Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.

  2004cited by this paper
• Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer

  2003cited by this paper
• Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

  2003cited by this paper
• Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.

  2003cited by this paper
• 45 Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial of the UK NCRI upper GI clinical studies group (the MAGIC trial, ISRCTN 93793971)

  2003cited by this paper
• Possible chemoresistance‐related genes for gastric cancer detected by cDNA microarray

  2003cited by this paper
• De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

  2002cited by this paper
• Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• A systematic overview of chemotherapy effects in gastric cancer.

  2001cited by this paper
• Cumulative results of chemosensitivity tests for antitumor agents in Japan. Japan Research Society for Appropriate Cancer Chemotherapy.

  2000cited by this paper
• Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5‐Fluorouracil

  2000cited by this paper
• Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group.

  2000cited by this paper
• Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

  2000cited by this paper
• Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

  2000cited by this paper
• Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

  1999cited by this paper
• Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.

  1999cited by this paper
• Meta-Analysis of Adjuvant Chemotherapy Trials for Gastric Cancer at the Cancer Institute Hospital, Tokyo

  1999cited by this paper
• ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

  1998cited by this paper
• Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer.

  1998cited by this paper
• Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.

  1998cited by this paper
• Chemotherapy of gastric cancer.

  1996cited by this paper
• Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.

  1996cited by this paper
• Clinical applications of the histoculture drug response assay.

  1995cited by this paper
• Potential of the histoculture drug-response assay to contribute to cancer patient survival.

  1995cited by this paper
• Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal.

  1994cited by this paper
• Single‐cell Suspension Assay with an MTT End Point Is Useful for Evaluating the Optimal Adjuvant Chemotherapy for Advanced Gastric Cancer

  1994cited by this paper
• Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

  1993cited by this paper
• Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.

  1992cited by this paper
• High in vitro‐in vivo correlation of drug response using sponge‐gel‐supported three‐dimensional histoculture and the MTT end point

  1992cited by this paper
• Clinical usefulness of chemosensitivity testing using the MTT assay

  1991cited by this paper
• Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay

  1989cited by this paper
• MTT assay with reference to the clinical effect of chemotherapy

  1989cited by this paper
• Chemotherapy of advanced gastric cancer: present status, future prospects.

  1988cited by this paper
• Chemotherapy of advanced gastric cancer: present status, future prospects.

  1988cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• CHEMOTHERAPY OF GASTRIC CANCER.

  1964cited by this paper

• Monitoring of drug resistance towards reducing the toxicity of pharmaceutical compounds: Past, present and future.

  2020cites this paper
• Tumor In Vitro Chemosensitivity and Chemoresistance Assays

  2019cites this paper
• Research and development of anticancer agents under the guidance of biomarkers

  2019cites this paper
• Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients

  2019cites this paper
• Novel biomarkers in cancer: The whole is greater than the sum of its parts.

  2017cites this paper
• Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

  2016cites this paper
• Prediction of Cancer Drug Resistance and Implications for Personalized Medicine

  2015cites this paper
• Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells.

  2015cites this paper
• Drug sensitivity testing platforms for gastric cancer diagnostics

  2015cites this paper
• Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

  2014influential citation
• Metabolomic studies of human gastric cancer: review.

  2014cites this paper
• Individualized Tumor Therapy: Biomarkers and Possibilities for Targeted Therapy with Natural Products

  2014cites this paper
• Oncogramme, an Adapted Method for Individualized Tumour Response Testing of Ovary Cancer Treatments

  2013cites this paper
• Clinical and Experimental Studies in Peritoneal Metastases from Gastric Cancer

  2013cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 886 Clinical and Experimental Studies in Peritoneal Metastases from Gastric Cancer

  2013cites this paper
• Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer.

  2012cites this paper
• Oncogramme, a new promising method for individualized breast tumour response testing for cancer treatment.

  2011cites this paper
• Metastatic lymph node targeted chemosensitivity test for gastric cancer.

  2011cites this paper
• Current Status of Methods to Assess Cancer Drug Resistance

  2011cites this paper
• Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively

  2010cites this paper
• A metabonomic approach to chemosensitivity prediction of cisplatin plus 5‐fluorouracil in a human xenograft model of gastric cancer

  2010cites this paper
• Oncogramme, a new individualized tumor response testing method: application to colon cancer

  2010cites this paper
• Predictive tests for individualization of pharmacological cancer treatment.

  2008cites this paper
• Collagen gel droplet-embedded culture drug-sensitivity test and potential for personalizing cancer treatment.

  2007cites this paper
• Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges

  2007cites this paper